Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes
- 1 November 2014
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 454 (3) , 410-416
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81170172, 81370284)
- Guangdong Department of Science & Technology Translational Medicine Center (2011A080300002)
- Junhong Company
This publication has 24 references indexed in Scilit:
- Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidaseJournal of Molecular and Cellular Cardiology, 2013
- Involvement of Kv1.5 Protein in Oxidative Vascular Endothelial Cell InjuryPLOS ONE, 2012
- Hypoxia Selectively Inhibits KCNA5 Channels in Pulmonary Artery Smooth Muscle CellsAnnals of the New York Academy of Sciences, 2009
- Kv1.5 Blockers for the Treatment of Atrial Fibrillation: Approaches to Optimization of Potency and Selectivity and Translation to In Vivo PharmacologyCurrent Topics in Medicinal Chemistry, 2009
- The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancerAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial FibrillationJACC, 2008
- Atrial Fibrillation: A PerspectiveCirculation, 2004
- Blockers of the Kv1.5 Channel for the Treatment of Atrial Arrhythmias [1]Current Medicinal Chemistry-Cardiovascular & Hematological Agents, 2003
- Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardiumCardiovascular Research, 2002